Meuwissen OJ - Search Results

1

VAD chemotherapy for refractory multiple myeloma.

Lokhorst HM, Meuwissen OJ, Bast EJ, Dekker AW. Lokhorst HM, et al. Among authors: meuwissen oj. Br J Haematol. 1989 Jan;71(1):25-30. doi: 10.1111/j.1365-2141.1989.tb06269.x. Br J Haematol. 1989. PMID: 2644970

2

Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.

Terpstra WE, Lokhorst HM, Blomjous F, Meuwissen OJ, Dekker AW. Terpstra WE, et al. Among authors: meuwissen oj. Br J Haematol. 1992 Sep;82(1):46-9. doi: 10.1111/j.1365-2141.1992.tb04592.x. Br J Haematol. 1992. PMID: 1419801

3

High-risk multiple myeloma treated with high-dose melphalan.

Lokhorst HM, Meuwissen OJ, Verdonck LF, Dekker AW. Lokhorst HM, et al. Among authors: meuwissen oj. J Clin Oncol. 1992 Jan;10(1):47-51. doi: 10.1200/JCO.1992.10.1.47. J Clin Oncol. 1992. PMID: 1727925

4

Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma.

Lokhorst HM, Sonneveld P, Wijermans PW, van Marwijk Kooy M, Meuwissen OJ, van Oers RH, van der Griend R, Dekker AW. Lokhorst HM, et al. Among authors: meuwissen oj. Br J Haematol. 1996 Jan;92(1):44-8. doi: 10.1046/j.1365-2141.1996.00306.x. Br J Haematol. 1996. PMID: 8562409 Clinical Trial.

5

Multiple myeloma and acute megakaryoblast leukemia in spent phase polycythemia vera.

Terpstra WE, Meuwissen OJ, Hagemeijer A, Michiels JJ. Terpstra WE, et al. Among authors: meuwissen oj. Am J Clin Pathol. 1990 Dec;94(6):786-90. doi: 10.1093/ajcp/94.6.786. Am J Clin Pathol. 1990. PMID: 2244596

6

Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.

de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, Hart HC, Sixma JJ, Nieuwenhuis HK. de Valk HW, et al. Among authors: meuwissen oj. Ann Intern Med. 1995 Jul 1;123(1):1-9. doi: 10.7326/0003-4819-123-1-199507010-00001. Ann Intern Med. 1995. PMID: 7539233 Clinical Trial.

7

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

van der Griend R, Haas FJ, Biesma DH, Duran M, Meuwissen OJ, Banga JD. van der Griend R, et al. Among authors: meuwissen oj. Atherosclerosis. 1999 Mar;143(1):177-83. doi: 10.1016/s0021-9150(98)00273-1. Atherosclerosis. 1999. PMID: 10208493

8

[Hyperhomocysteinemia as risk factor for premature atherosclerosis].

van der Griend R, Meuwissen OJ. van der Griend R, et al. Among authors: meuwissen oj. Ned Tijdschr Geneeskd. 1994 Feb 26;138(9):456-9. Ned Tijdschr Geneeskd. 1994. PMID: 8133946 Dutch. No abstract available.

9

Methionine loading test is necessary for detection of hyperhomocysteinemia.

van der Griend R, Haas FJ, Duran M, Biesma DH, Meuwissen OJ, Banga JD. van der Griend R, et al. Among authors: meuwissen oj. J Lab Clin Med. 1998 Jul;132(1):67-72. doi: 10.1016/s0022-2143(98)90027-0. J Lab Clin Med. 1998. PMID: 9665374

10

The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations.

van der Griend R, Biesma DH, Haas FJ, Faber JA, Duran M, Meuwissen OJ, Banga JD. van der Griend R, et al. Among authors: meuwissen oj. J Intern Med. 2000 Sep;248(3):223-9. doi: 10.1046/j.1365-2796.2000.00726.x. J Intern Med. 2000. PMID: 10971789 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters